Glucose-6-phosphate dehydrogenase (G6PD) deficiency is currently a threat to malaria elimination due to risk of primaquine-induced haemolysis in G6PD deficient individuals. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.